Case 33-2004: A 34-year-old man with a seizure and a frontal-lobe brain lesion

New England Journal of Medicine

Volumn 351, Issue 18, 2004, Pages 1875-1882

  Eskandar, Emad N ^a   Loeffler, Jay S ^a   O'Neill, Alison M ^a   Hunter, George J ^a   Louis, David N ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYTOIN;

ADULT; ARTICLE; BRAIN BIOPSY; CASE REPORT; CHRONIC VEIN INSUFFICIENCY; COMPUTER ASSISTED TOMOGRAPHY; CRANIOTOMY; DEEP VEIN THROMBOSIS; DIFFERENTIAL DIAGNOSIS; FRONTAL LOBE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SEIZURE; SLEEP APNEA SYNDROME; STEREOTAXIC SURGERY; THROMBECTOMY; BRAIN; BRAIN TUMOR; CHROMOSOME DELETION; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; GENETICS; METABOLISM; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; RADIOGRAPHY; VEIN THROMBOSIS;

ADULT; BRAIN; BRAIN NEOPLASMS; CHROMOSOME DELETION; COMBINED MODALITY THERAPY; CRANIOTOMY; DIAGNOSIS, DIFFERENTIAL; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; OLIGODENDROGLIOMA; SEIZURES; SLEEP APNEA, OBSTRUCTIVE; STEREOTAXIC TECHNIQUES; TOMOGRAPHY, X-RAY COMPUTED; VENOUS THROMBOSIS;

EID: 6944253542     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMcpc049025     Document Type: Article

References (18)

1. Dehghani F, Schachenmayr W, Laun A, Korf HW. Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: a study of 89 cases. Acta Neuropathol (Berl) 1998;95:493-504.
2. Shaw EG, Scheithauer BW, O'Fallon JR, Tazelaar HD, Davis DH. Oligodendrogliomas: the Mayo Clinic experience. J Neurosurg 1992;76:428-34.
3. Schiffer D, Dutto A, Cavalla P, et al. Prognostic factors in oligodendroglioma. Can J Neurol Sci 1997;24:313-9.
4. Winger MJ, Macdonald DR, Cairncross JG. Supratentorial anaplastic gliomas in adults: the prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg 1989;71:487-93.
5. Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998;90:1473-9.
6. Ino Y, Betensky RA, Zlatescu MC, et al. Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin Cancer Res 2001;7:839-45.
7. Smith JS, Perry A, Borell TJ, et al. Alterations of chromosome arms lp and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 2000;18:636-45.
8. von Deimling A, von Ammon K, Schoenfeld D, Wiestler OD, Seizinger BR, Louis DN. Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 1993;3:19-26.
9. Watanabe K, Tachibana O, Sata K, Yonekawa Y, Kleihues P, Ohgald H. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 1996;6:217-23.
10. Reifenberger J, Ring GU, Gies U, et al. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression. J Neuropathol Exp Neurol 1996;55:822-31.
11. Meyer-Puttlitz B, Hayashi Y, Waha A, et al. Molecular genetic analysis of giant cell glioblastomas. Am J Pathol 1997;151:853-7.
12. Tortosa A, Ino Y, Odell N, et al. Molecular genetics of radiographically defined de novo glioblastoma multiforme. Neuropathol Appl Neurobiol 2000;26:544-52.
13. Burger PC, Pearl DK, Aldape K, et al. Small cell architecture - a histological equivalent of EGFR amplification in glioblastoma multiforme? J Neuropathol Exp Neurol 2001;60:1099-104.
14. Simmons ML, Lamborn KR, Takahashi M, et al. Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients. Cancer Res 2001;61:1122-8.
15. Cairncross JG, Macdonald DR. Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol 1988;23:360-4.
16. Cairncross G, Macdonald D, Ludwin S, et al. Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 1994;12:2013-21.
17. Bauman GS, Ino Y, Ueld K, et al. Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas. Int J Radiat Oncol Biol Phys 2000;48:825-30.
18. Kooy HM, van Herk M, Barnes PD, et al. Image fusion for stereotactic radiotherapy and radiosurgery treatment planning. Int J Radiat Oncol Biol Phys 1994;28:1229-34.